AKR1B10: A potential target for cancer therapy

Bioscience Hypotheses

Volumn 2, Issue 1, 2009, Pages 31-33

  Zu, Xuyu ^a,b   Yan, Ruilan ^a   Ma, Jun ^a   Liao, Duan Fang ^b   Cao, Deliang ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AKR1B10; Cancer therapy; Retinoic acid metabolism

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ALDEHYDE REDUCTASE; ALDOSE REDUCTASE LIKE 1 PROTEIN; DAUNORUBICIN; ORACIN; RETINAL; RETINOIC ACID; RETINOL; SMALL INTERFERING RNA; TOLRESTAT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER RESISTANCE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG EFFICACY; DRUG TARGETING; ENZYME INHIBITION; HUMAN; LIVER CANCER; LIVER CELL CARCINOMA; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; SIGNAL TRANSDUCTION; SMOKING;

EID: 58149289666     PISSN: 17562392     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bihy.2008.07.011     Document Type: Article

References (20)

1. Penning T.M. Introduction and overview of the aldo-keto reductase superfamily. In: Penning T.M., and Petrash J.M. (Eds). Aldo-keto reductases and toxicant metabolism (2004), American Chemical Society, Washington (DC) 3-21
2. Hyndman D.J., and Flynn T.G. Sequence and expression levels in human tissues of a new member of the aldo-keto reductase family. Biochim Biophys Acta 1399 (1998) 198-202
3. Cao D.L., Fan S.T., and Chung S.S.M. Identification and characterization of a novel human aldose reductase like gene. J Biol Chem 273 (1988) 11429-11435
4. Zu X., Yan R., Robbins S., Krishack P.A., Liao D.-F., and Cao D. Reduced 293T cell susceptibility to acrolein due to aldose reductase-like-1 protein expression. Toxicol Sci 97 (2007) 562-568
5. Yan R., Zu X., Ma J., Liu Z., Adeyanju M., and Cao D. Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: implication for cancer intervention. Int J Cancer 121 (2007) 2301-2306
6. Fukumoto S.-I., Yamauchi N., Moriguchi H., Hippo Y., Watanabe A., Shibahara J., et al. Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas. Clin Cancer Res 11 (2005) 1776-1785
7. Lia C.-P., Gotoa A., Watanabeb A., Murataa K., Otaa S., Nikic T., et al. AKR1B10 in usual interstitial pneumonia: expression in squamous metaplasia in association with smoking and lung cancer. Pathol Res Pract 204 (2008) 295-304
8. Breton J., Gage M.C., Hay A.W., Keen J.N., Wild C.P., Donnellan C., et al. Proteomic screening of a cell line model of esophageal carcinogenesis identifies cathepsin D and aldo-keto reductase 1C2 and 1B10 dysregulation in Barrett's esophagus and esophageal adenocarcinoma. J Proteome Res 7 (2008) 1953-1962
9. Bacolod M.D., Lin S.M., Johnson S.P., Bullock N.S., Colvin M., Bigner D.D., et al. The gene expression profiles of medulloblastoma cell lines resistant to preactivated cyclophosphamide. Curr Cancer Drug Targets 8 (2008) 172-179
10. Crosas B., Hyndman D.J., Gallego O., Martras S., Parés X., Flynn T.G., et al. Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism. Biochem J 373 (2003) 973-979
11. Gallego O., Belyaeva O.V., Porté S., Ruiz F.X., Stetsenko A.V., Shabrova E.V., et al. Comparative functional analysis of human medium-chain dehydrogenases, short-chain dehydrogenases/reductases and aldo-keto reductases with retinoids. Biochem J 399 (2006) 101-109
12. Blaner W.S., and Olson J.A. In: Sporn M.B., Roberts A.B., and Goodman D.S. (Eds). The retinoids: biology, chemistry and medicine (1994), Raven, New York 229-255
13. Penning T.M. AKR1B10: a new diagnostic marker of non-small cell lung carcinoma in smokers. Clin Cancer Res 11 (2005) 1687-1690
14. Martin H.J., Breyer-Pfaff U., Wsol V., Venz S., Block S., and Maser E. Purification and characterization of AKR1B10 from human liver: role in carbonyl reduction of xenobiotics. Drug Metab Dispos 34 (2006) 464-470
15. Jiang H., Shen Y., Quinn A.M., and Penning T.M. Competing roles of cytochrome P450 1A1/1B1 and aldo-keto reductase 1A1 in the metabolic activation of (+)-7,8-dihydroxy-7, 8-dihydro-benzo [a]pyrene in human bronchoalveolar cell extracts. Chem Res Toxicol 18 (2005) 365-374
16. Ma J., Yan R., Zu X., Chen J., and Cao D. Aldo-keto reductase family 1 B10 associates with acetyl-CoA carboxylase in colon and breast cancer cells. J Biol Chem 283 (2008) 3418-3423
17. Zeindl-Eberhart E., Haraida S., Liebmann S., Jungblut P.R., Lamer S., Mayer D., et al. Detection and identification of tumor-associated protein variants in human hepatocellular carcinomas. Hepatology 39 (2004) 540-549
18. Nagaraj N.S., Beckers S., Mensah J.K., Waigel S., Vigneswaran N., and Zacharias W. Cigarette smoke condensate induces cytochromes P450 and aldo-keto reductases in oral cancer cells. Toxicol Lett 165 (2006) 182-194
19. Gallego O., Ruiz F.X., Ardevol A., Dominguez M., Alvarez R., de Lera A.R., et al. Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10. Proc Natl Acad Sci U S A 104 (2007) 20764-20769
20. Ehrig T., Bohren K.M., Prendergast F.G., and Gabbay K.H. Mechanism of aldose reductase inhibition: binding of NADP+/NADPH and alrestatin-like inhibitors. Biochemistry 33 (1994) 7157-7165